CKD. Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease
Conditions
Interventions
Intervention group: This study is done with a sample size of 99 dialysis patients from Razi Hospital who will be selected by simple sampling method. These patients will undergo dialysis with the same
Sponsors
Rasht University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Dialysis patients undergoing hemodialysis three times a week History of hemodialysis at least three months before the study The desire to participate in the study
Exclusion criteria
Exclusion criteria: Cardiovascular Disease Thyroid Disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Systolic blood pressure changes. Timepoint: Initially, during and after dialysis at each stage of hemodialysis. Method of measurement: Digital manometer.;Diastolic blood pressure changes. Timepoint: Initially, during and after dialysis at each stage of hemodialysis. Method of measurement: Digital manometer.;Heart rate changes. Timepoint: Initially, during and after dialysis at each stage of hemodialysis. Method of measurement: Digital manometer.;Adequacy of dialysis. Timepoint: First and the end of third turn of dialysis at two different temperatures. Method of measurement: Measuring blood BUN and calculating based on Daugirdas-II formula. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMajid Pourshaikhian
Rasht University of Medical Sciences
Outcome results
None listed